Inexia Limited

Industry

  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Nasal

Other Names/Subsidiaries

  • Centessa Pharmaceuticals, Orexia Therapeutics
See more in Biomedtracker

Latest on Inexia Limited

Scrip

Sosei Heptares Bags Second GPCR Targets Deal In A Month, With Takeda

 
• By Sten Stovall

Sosei Heptares has entered a strategic multi-target partnership with Takeda Pharmaceutical Co. Ltd. to discover, develop and commercialize novel molecules, including small molecules and biologics,

Scrip

Venture Funding Deals: Spin-Outs From Axovant, Inovio & Sosei

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Series E Brings $18m To 3-V Biosciences 3-V Biosciences Inc. , which is developing drugs for cancer and nonalcoholic steatohepatitis (NASH), raised $18m through its Series E round. New investor and p

Scrip

Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

 
• By Joseph Haas, Jung Won Shin, Brian Yang, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Arvelle To Commercialize SK’

Scrip

Finance Watch: 5AM, Longevity Close Funds, New Incubators Launch To Support Early-Stage Companies

 
• By Mandy Jackson

Both start-ups and established companies will benefit from 5AM Venture Management LLC's two new funds totaling $497m, increasing the San Francisco-based venture capital firm's capital raised to date t